TYLE PRAVEEN
Insider CIK 1296936 · LXRX EVP, R&D · EYEG Director · SKYE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KPRX KIORA PHARMACEUTICALS INC | A Award deriv | 2026-06-10 | 2026-06-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KPRX KIORA PHARMACEUTICALS INC | A Award deriv | 2025-04-01 | 2025-04-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KPRX KIORA PHARMACEUTICALS INC | P Buy | 2024-08-19 | 2024-08-19 | 5,000 | $3.96 | $19.8K | 5,014 | SEC↗ |
| KPRX KIORA PHARMACEUTICALS INC | A Award deriv | 2024-07-01 | 2024-07-03 | 1,778 | — | $0 | 1,778 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2024-02-29 | 2024-03-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2023-11-06 | 2023-11-06 | 14,110 | — | $0 | 20,001 | SEC↗ |
| KPRX KIORA PHARMACEUTICALS INC | A Award deriv | 2023-09-29 | 2023-10-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2023-08-25 | 2023-08-29 | 1,472,692 | — | $0 | 1,472,692 | SEC↗ |
| KPRX KIORA PHARMACEUTICALS INC | A Award deriv | 2023-03-03 | 2023-03-07 | 8,000 | — | $0 | 8,000 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2023-01-05 | 2023-01-06 | 250,000 | — | $0 | 250,000 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2023-01-05 | 2023-01-09 | 250,000 | — | $0 | 250,000 | SEC↗ |
| KPRX KIORA PHARMACEUTICALS INC | A Award deriv | 2022-02-01 | 2022-02-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2021-09-14 | 2021-09-16 | 25,000 | — | $0 | 275,000 | SEC↗ |
| SKYE Skye Bioscience, Inc. | A Award deriv | 2021-07-22 | 2021-07-26 | 250,000 | — | $0 | 250,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 28,690 | — | $0 | 57,380 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 26,600 | — | $0 | 26,600 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 9,727 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 2,990 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 2,990 | — | $0 | 72,334 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 9,727 | — | $0 | 82,061 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 26,600 | — | $0 | 108,661 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2021-02-28 | 2021-03-02 | 16,560 | $7.19 | $119.1K | 120,791 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 28,690 | — | $0 | 137,351 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 32,100 | — | $0 | 32,100 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 96,310 | — | $0 | 96,310 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | A Award deriv | 2021-02-01 | 2021-02-03 | 3,333 | — | $0 | 3,333 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2020-04-22 | 2020-04-24 | 19,893 | — | $0 | 74,188 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2020-04-22 | 2020-04-24 | 4,844 | $1.96 | $9.5K | 69,344 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 26,600 | — | $0 | 53,200 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 9,726 | — | $0 | 9,727 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 2,990 | — | $0 | 2,990 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 2,990 | — | $0 | 17,969 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 9,726 | — | $0 | 27,695 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 26,600 | — | $0 | 54,295 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | A Award deriv | 2020-02-14 | 2020-02-19 | 3,333 | — | $0 | 3,333 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-02-06 | 2020-02-10 | 258,210 | — | $0 | 258,210 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-02-06 | 2020-02-10 | 86,070 | — | $0 | 86,070 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 9,727 | — | $0 | 19,453 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 2,990 | — | $0 | 5,980 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 9,727 | — | $0 | 14,979 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 2,990 | — | $0 | 5,252 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-02-07 | 2019-02-08 | 79,800 | — | $0 | 79,800 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-02-07 | 2019-02-08 | 148,200 | — | $0 | 148,200 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | A Award deriv | 2019-02-01 | 2019-02-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | A Award | 2018-07-10 | 2018-07-12 | 50,000 | — | $0 | 61,893 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 2,990 | — | $0 | 8,970 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 2,990 | — | $0 | 2,990 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2018-02-28 | 2018-03-02 | 728 | $8.53 | $6.2K | 2,262 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2018-02-08 | 2018-02-12 | 82,820 | — | $0 | 82,820 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2018-02-08 | 2018-02-12 | 29,180 | — | $0 | 29,180 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | A Award deriv | 2017-06-21 | 2017-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2017-02-09 | 2017-02-13 | 47,860 | — | $0 | 47,860 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2017-02-09 | 2017-02-13 | 11,960 | — | $0 | 11,960 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2016-05-16 | 2016-05-16 | 100,000 | — | $0 | 100,000 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | A Award deriv | 2016-03-29 | 2016-03-31 | 7,282 | — | $0 | 7,282 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | A Award deriv | 2016-01-25 | 2016-01-27 | 3,000 | — | $0 | 3,000 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | A Award deriv | 2015-08-28 | 2015-09-01 | 8,000 | — | $0 | 8,000 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | A Award | 2015-08-28 | 2015-09-01 | 5,748 | — | $0 | 11,893 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | A Award | 2015-05-01 | 2015-05-05 | 11,893 | — | $0 | 11,893 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | A Award deriv | 2015-02-24 | 2015-02-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EYEG EYEGATE PHARMACEUTICALS IN | A Award deriv | 2015-02-19 | 2015-02-23 | 2,276 | — | $0 | 36,051 | SEC↗ |